About Primary Hyperoxaluria Type 3

Hyperoxaluria, Primary, Type Iii, also known as primary hyperoxaluria type 3, is related to primary hyperoxaluria and nephrolithiasis, calcium oxalate. An important gene associated with Hyperoxaluria, Primary, Type Iii is HOGA1 (4-Hydroxy-2-Oxoglutarate Aldolase 1), and among its related pathways/superpathways are PERK regulates gene expression and Glyoxylate metabolism and glycine degradation. The drugs Omalizumab and Mupirocin have been mentioned in the context of this disorder. Affiliated tissues include kidney, pancreas and skeletal muscle, and related phenotypes are hematuria and nephrocalcinosis

Major Symptoms of Primary Hyperoxaluria Type 3

Primary hyperoxaluria type 3, also known as Wilson's disease, is a rare genetic metabolic disorder characterized by inflammation of the kidneys and lungs. The main symptoms of patients include:

1. Chronic cough: Patients often have persistent dry cough, expectoration, and shortness of breath when coughing.

2. Shortness of breath: Patients may feel short of breath or even have difficulty breathing.

3. Fatigue: Patients often feel tired, weak, and lack energy.

4. Weight loss: Patients may experience weight loss.

5. Skin lesions: Patients may develop skin lesions, including skin cyanosis, skin inflammation, and skin ulcers.

6. Pulmonary disease: Patients may develop lung inflammation, including pneumonia and interstitial pneumonia.

7. Kidney damage: Patients may develop kidney damage, including renal insufficiency and nephritis. It should be noted that these symptoms are not necessarily the main symptoms of Primary hyperoxaluria type 3, because the symptoms of patients may vary depending on individual differences. If you have relevant symptoms, please seek medical treatment promptly and receive a professional diagnosis.

Suitable Lifestyle for People with Primary Hyperoxaluria Type 3

The patient suffers from Primary hyperoxaluria type 3, a hereditary kidney disease characterized by damage to the glomerular filtration membrane and abnormal renal tubular function. Therefore, patients should adopt a healthy lifestyle to alleviate the condition and delay the progression of the disease. Patients are advised to follow the following lifestyle:

1. Control weight: Patients should lose weight to reduce the burden on the kidneys. Patients are advised to follow a low-calorie, low-fat, and low-salt diet to help with weight control.

2. Follow medication: Patients may need medication to reduce symptoms and control disease progression. Patients are advised to take medications as recommended by their doctors and follow their medication instructions.

3. Appropriate exercise: Appropriate exercise can improve the body's immunity, alleviate the condition and improve the patient's quality of life. It is recommended that patients do moderate exercise, such as walking, jogging, etc.

4. Avoid overexertion: Patients should avoid overexertion to reduce the burden on the kidneys. Patients are advised to adopt light work and recreational activities and ensure adequate rest time.

5. Regular check-ups: Patients should have regular check-ups to monitor disease progression and detect and deal with problems in a timely manner. It is recommended that patients go to the hospital for regular check-ups and follow the doctor's recommendations for treatment.

Other Diseases

Primary Hyperoxaluria Type 1Primary HyperoxaluriaHyperoxaluriaPrimary AldosteronismPrimary HyperparathyroidismPrimary ErythromelalgiaPrimary Progressive AphasiaPrimary Lateral SclerosisCongenital Primary AphakiaPrimary Ovarian InsufficiencyPrimary Sclerosing CholangitisPrimary Carnitine DeficiencyPrimary Torsion DystoniaPrimary Cutaneous AmyloidosisPrimary Biliary CholangitisPersistent Hyperplastic Primary VitreousPrimary Progressive Nonfluent AphasiaPrimary Familial Brain CalcificationPrimary Progressive Multiple SclerosisAutosomal Recessive 1 Primary Hypertrophic Osteoarthropathy